Larvol Delta - CA4948101-OpenLabel-Dose-Escalation-and-Expansion-Trial-of-Emavusertib-CA4948-in-Relapsed-or-Refractory-Primary-Central-Nervous-System-Lymphoma-RR-PCNSL

Imbruvica (ibrutinib) - AbbVie, J&J

emavusertib (CA-4948) - Curis, Dr. Reddy’s

http://clinicaltrials.gov/ct2/show/NCT03328078

Sep 8, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next